PetCure Oncology says it has now treated 10,000 pets

PetCure Oncology said it has now treated 10,000 pets with radiation therapy since opening in 2015, a milestone the company framed as evidence of how veterinary access to advanced radiation oncology has expanded beyond academic centers. In a January 7, 2026 article, the Thrive Pet Healthcare partner said it now operates eight treatment centers nationwide and supports referrals with a clinical team that includes 12 board-certified oncologists and eight supervising veterinarians. The company said its model has centered on making stereotactic radiation therapy more available in community referral settings, with many cases completed in one to three sessions instead of the historically longer treatment courses used in conventional radiation. (petcureoncology.com)

Why it matters: For veterinarians, the milestone is less about a round number than what it says about referral infrastructure. PetCure’s growth points to a broader shift in veterinary oncology: stereotactic radiation is becoming a more practical option for patients outside university hospitals, supported by telehealth consults, multi-site treatment planning, and a larger specialist network. That matters in a field where the specialist workforce remains relatively small, with the American College of Veterinary Radiology reporting 129 active radiation oncology diplomates in 2022, and where referral access, anesthesia burden, travel, and treatment time can all shape whether pet parents pursue care. (petcureoncology.com)

What to watch: Watch whether PetCure adds more centers or technology partnerships in 2026, as it has already signaled expansion efforts and new platform deployment in the Seattle market. (empyreanmed.com)